Vibrant Gastro announced today the publication of new real-world evidence in Clinical and Translational Gastroenterology demonstrating the long-term effectiveness and safety of the Vibrant System™, a ...

Millions of adults all over the world endure chronic constipation — an awkward situation marked by hard, painful, or infrequent bowel movements which disrupt daily life. Even though prevalent, advice ...

The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

Home remedies, over-the-counter (OTC) medications, and other self-care methods often deliver constipation relief. Exercise ...

Gastroenterologist Joe Soliman, MD, answers questions about when to treat chronic idiopathic constipation (CIC) and what your options are. Most everyone gets constipated from time to time. When does ...

LEXINGTON, Mass., April 2, 2019 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc., ("Takeda") today announced that Motegrity ™ (prucalopride), a once-daily, oral treatment option, is now ...

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...

Big-gun pain relievers can come with unwelcome side effects. At the top of the list for many of these products are constipation and the distress of slowed bowels.

Constipation is a serious health issue in India, which impacts 22 per cent of our country’s population daily. There is no universally accepted definition for constipation, but if you experience bowel ...

The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for ...